ProtaGene

ProtaGene is a global contract research organization that delivers end-to-end analytical services for biopharmaceuticals, gene, and cell therapies. Leveraging a unique blend of protein-based and gene-vector analytics—originating from the merger of Protagen Protein Services and BioAnalytix, and expanded with GeneWerk’s vector safety and bioinformatics expertise—the company provides advanced mass spectrometry, integration site analysis, and drug-development support from discovery through commercialization. With four strategically located sites across Europe and North America, ProtaGene partners with leading biopharma and gene-therapy companies worldwide to accelerate the development of biologic therapeutics and next-generation cellular products. Its integrated, technology-rich platform and deep analytical leadership position it as a distinctive partner for companies seeking comprehensive, high-precision analytics in the rapidly evolving therapeutic landscape.